Rachel Adams Greenup, MD, MPH, FACS, has been appointed Associate Professor of Surgery (Oncology) and Section Chief of Breast Surgery for the Department of Surgery at Yale School of Medicine. In her new role, Dr. Greenup will provide breast surgical oncology leadership across the Smilow Cancer Hospital Network and Care Centers.
Rachel Adams Greenup, MD, MPH, FACS
Mehra Golshan, MD, MBA, FACS
“Dr. Greenup is the rare triple threat in surgery, bringing compassionate, patient-centered breast cancer care, outcomes research, and her extensive leadership capabilities. This will be an asset to our hospital and for our patients. I am excited to welcome her to Smilow Cancer Hospital and to Yale Cancer Center and look forward to working together,” said Mehra Golshan, MD, MBA, FACS, Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital, Clinical Director of the Smilow Cancer Hospital Breast Cancer Program, and Professor of Surgery (Oncology) at Yale School of Medicine.
“Yale has a long-standing reputation as a renowned school of medicine, bringing together outstanding clinicians and scientists dedicated to reducing the burden of cancer,” Dr. Greenup said. “I am honored to lead the breast surgical oncology program and committed to further developing the extraordinary clinical care, collaborative research, and mentorship for which Yale is known, with our patients at the center of this mission.”
Dr. Greenup joins Yale from Duke University, where she is Associate Professor of Surgery and Population Health Sciences at the Duke University School of Medicine and Duke Cancer Institute. She currently serves as Deputy Director of the Duke Surgical Center for Outcomes Research and is a core faculty member for the Duke Margolis Center for Health Policy. She founded and co-directs the Duke Breast Cancer Outcomes Research Group.
In 2016, Dr. Greenup received the National Institutes of Health Building Interdisciplinary Research Careers in Women’s Health Award to evaluate how financial costs and burdens relate to preference-sensitive decisions for breast cancer surgery. In 2017, she was named the American College of Surgeons and the American Society of Breast Surgeons Health Policy Scholar. Dr. Greenup previously served as the Duke Breast Surgical Oncology Fellowship Director.